Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
DocGo Inc (DCGO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: DCGO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $3.05
1 Year Target Price $3.05
| 3 | Strong Buy |
| 1 | Buy |
| 3 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -34.64% | Avg. Invested days 30 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 158.57M USD | Price to earnings Ratio - | 1Y Target Price 3.05 |
Price to earnings Ratio - | 1Y Target Price 3.05 | ||
Volume (30-day avg) 7 | Beta 0.94 | 52 Weeks Range 1.23 - 5.67 | Updated Date 06/29/2025 |
52 Weeks Range 1.23 - 5.67 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.01 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.12% | Operating Margin (TTM) -14.58% |
Management Effectiveness
Return on Assets (TTM) -0.16% | Return on Equity (TTM) -2.7% |
Valuation
Trailing PE - | Forward PE 60.24 | Enterprise Value 140416090 | Price to Sales(TTM) 0.3 |
Enterprise Value 140416090 | Price to Sales(TTM) 0.3 | ||
Enterprise Value to Revenue 0.27 | Enterprise Value to EBITDA 9.57 | Shares Outstanding 99104304 | Shares Floating 86920445 |
Shares Outstanding 99104304 | Shares Floating 86920445 | ||
Percent Insiders 7.11 | Percent Institutions 59.17 |
Analyst Ratings
Rating 3 | Target Price 3.05 | Buy 1 | Strong Buy 3 |
Buy 1 | Strong Buy 3 | ||
Hold 3 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
DocGo Inc
Company Overview
History and Background
DocGo Inc. (formerly Motion Acquisition Corp.) was founded in 2015. It went public via SPAC in November 2021. DocGo provides mobile health and remote patient monitoring services.
Core Business Areas
- Mobile Health Services: On-demand medical care delivered to patients' homes or other locations, including testing, vaccinations, and chronic disease management.
- Remote Patient Monitoring: Technology-enabled monitoring of patients' vital signs and health data from a distance, enabling proactive interventions.
- Ambulnz: Acquired in 2021, provides ambulance transportation and medical support services.
Leadership and Structure
Anthony Capone (President), Lee Bienstock (COO), and Norman Rosenberg (Chairman). The company operates with a hierarchical structure with regional leadership teams overseeing local operations.
Top Products and Market Share
Key Offerings
- On-Demand Medical Services: Delivery of medical care directly to patients' locations. Revenue for 2023 was $508.3M. Competitors include Dispatch Health, Ready Responders and Cityblock Health.
- Remote Patient Monitoring (RPM): Real-time monitoring of patients' health data from a distance. Competitors include BioTelemetry, Teladoc Health, and Omron Healthcare.
- Ambulance Services: Ambulance services to provide medical transport to patients. DocGo's revenue from ambulance services are 40-50% of their total revenue. Competitors include Falck, Acadian Ambulance Service, and American Medical Response.
Market Dynamics
Industry Overview
The mobile health and remote patient monitoring market is experiencing rapid growth due to increasing demand for convenient and accessible healthcare, rising prevalence of chronic diseases, and advancements in technology.
Positioning
DocGo positions itself as a leading provider of mobile health and remote patient monitoring services, focusing on providing convenient, affordable, and high-quality care.
Total Addressable Market (TAM)
The TAM for mobile health is estimated to be several billion dollars and expected to grow substantially. DocGo is positioned to capture a significant share of this market by expanding its service offerings and geographic reach.
Upturn SWOT Analysis
Strengths
- Innovative technology platform
- Strong partnerships with healthcare providers and payers
- Experienced management team
- Rapidly growing market share
- Scalable business model
Weaknesses
- Dependence on key contracts
- Competition from established players
- Regulatory uncertainty
- High customer acquisition costs
- Negative net income
Opportunities
- Expanding service offerings to include virtual care and telehealth
- Entering new geographic markets
- Acquiring complementary businesses
- Capitalizing on the shift towards value-based care
- Increasing focus on preventative care and wellness
Threats
- Increased competition from established players and new entrants
- Changes in healthcare regulations and reimbursement policies
- Economic downturn
- Data security and privacy breaches
- Difficulty retaining qualified personnel
Competitors and Market Share
Key Competitors
- AMR
- TDOC
- Dispatch Health
Competitive Landscape
DocGo Inc. competes with established players in the healthcare industry. Their mobile health services have a competitive edge.
Major Acquisitions
Ambulnz
- Year: 2021
- Acquisition Price (USD millions): 245
- Strategic Rationale: Acquisition of Ambulnz enabled DocGo to expand its ambulance transportation and medical support services.
Growth Trajectory and Initiatives
Historical Growth: DocGo Inc. has experienced rapid revenue growth in recent years due to increased demand for mobile health and remote patient monitoring services.
Future Projections: Analysts predict continued revenue growth for DocGo Inc. but significant questions on the stock price, as the company's share price has continued to decline over the last few years.
Recent Initiatives: DocGo Inc. has recently expanded its service offerings to include virtual care and telehealth and has entered new geographic markets.
Summary
DocGo exhibits strong revenue growth but negative net income. The company's mobile health services and remote patient monitoring solutions capitalize on increasing demand. Successfully navigating regulatory challenges and competition will be crucial. DocGo will have to reduce customer acquisition costs to ensure they can make the necessary revenue to be profitable.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DocGo Inc
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2021-11-05 | CEO & Director Mr. Lee Bienstock | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 3404 | Website https://www.docgo.com |
Full time employees 3404 | Website https://www.docgo.com | ||
DocGo Inc. provides mobile health and medical transportation services in the United States and the United Kingdom. The company offers transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also provides mobile health services through its platform that are performed at home, offices, and other locations; event services, including on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was incorporated in 2015 and is headquartered in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.